Lupin logo

Lupin share news, announcements and annual reports

NSE: LUPINBSE: 500257Pharmaceuticals & BiotechnologyMid Cap

Lupin Limited · Face value ₹2 · Listed Oct 1993 on BSE, Sep 2001 on NSE
Last close ₹1,989.90up ₹17.20 (0.87%)BSE ₹1,998.00

Share price at the NSE close on 29 Oct 2026. Previous close ₹1,972.70.

29 Oct: open ₹1,977.40, high ₹1,999.60, low ₹1,962.30

52-week range of traded prices to 29 Oct 2026
₹1,892.90Low, 23 Oct 2026₹2,529.50High, 16 Jul 2026
Market cap
₹90,996 Cr105th largest listed
P/E
16.46
P/E without one-offs
14.95
P/B
4.05
Dividend yield
0.90%
ROE
27.9%
ROE without one-offs
30.7%
ROCE
28.2%
Debt to equity
0.26
Volume, NSE
7,81,45154.5% delivered

Lupin credit ratings

5 filed, newest first.

  1. Feb 2023

  2. Nov 2021

  3. Apr 2015

  4. Aug 2009

    • 4 Aug · Rating

      ICRA Limited has assigned the rating of "A1+" (pronounced "A One Plus") to the Company's Short Term Debt (including Commercial Paper) programme of Rs.250 crore (Enhancement from Rs.100 crore). "A1+" is the highest-credit-quality rating assigned by ICRA to short term debt instruments
  5. Apr 2008

    • 8 Apr · Rating

      ICRA Limited has assigned "A1+" (pronounced "A one plus") rating to the Company's bank limit for Fund based/Non-Fund based facilities aggregating Rs.7000 million. This rating is the highest credit quality rating assigned by ICRA for the short term